Literature DB >> 19767665

Complete remission of MDS RAEB following immunosuppressive treatment in a patient with Sweet's syndrome.

J Ten Oever1, P H M Kuijper, A L A Kuijpers, M W Dercksen, G Vreugdenhil.   

Abstract

We report on a patient with myelodysplastic syndrome (MDS), classified as refractory anaemia with excess of blasts-2, and histiocytoid Sweet's syndrome. The skin lesions disappeared after initiation of corticosteroids and doxycycline. Remarkably, two months later a complete remission of the MDS occurred. Fourteen months later both the skin lesions and the MDS relapsed. Antileukaemic activity following reversion of the impaired cellular immunity due to an increased number of natural killer cells in his bone marrow may be responsible for this rare event. Inhibition of T-cell mediated myelosuppression by corticosteroids or a proapoptotic effect of doxycycline may have attributed as well.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767665

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  5 in total

1.  Sweet's Syndrome with Myelodysplasia.

Authors:  Kashmira Jain; Sangeeta Mudaliar; Archana Swami
Journal:  Indian J Pediatr       Date:  2015-02-05       Impact factor: 1.967

2.  Clinicopathologic, Immunohistochemical, and Molecular Features of Histiocytoid Sweet Syndrome.

Authors:  Victoria Alegría-Landa; Socorro María Rodríguez-Pinilla; Angel Santos-Briz; José Luis Rodríguez-Peralto; Victor Alegre; Lorenzo Cerroni; Heinz Kutzner; Luis Requena
Journal:  JAMA Dermatol       Date:  2017-07-01       Impact factor: 10.282

3.  Histiocytoid Sweet Syndrome Is More Frequently Associated With Myelodysplastic Syndromes Than the Classical Neutrophilic Variant: A Comparative Series of 62 Patients.

Authors:  Lisa Ghoufi; Nicolas Ortonne; Saskia Ingen-Housz-Oro; Walid Barhoumi; Edouard Begon; Corinne Haioun; Cécile Pautas; Florence Beckerich; Christine Robin; Pierre Wolkenstein; Catherine Cordonnier; Olivier Chosidow; Andréa Toma
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 4.  The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications.

Authors:  Hassan Awada; Bicky Thapa; Valeria Visconte
Journal:  Cells       Date:  2020-11-20       Impact factor: 6.600

5.  Histiocytoid Sweet's syndrome in a patient with myelodsyplastic syndrome: report and review of the literature.

Authors:  Michael M Shalaby; Ryan R Riahi; Les B Rosen; Erik J Soine
Journal:  Dermatol Pract Concept       Date:  2016-01-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.